- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Maringele, L.
- Articles by Lydall, D.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Maringele, L.
- Articles by Lydall, D.
EXO1 Plays a Role in Generating Type I and Type II Survivors in Budding Yeast
Laura Maringele1,a and David Lydallaa School of Biological Sciences, University of Manchester, Manchester M13 9PT, United Kingdom
Corresponding author: David Lydall, University of Newcastle, Henry Wellcome Laboratory for Biogerontology Research, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, United Kingdom., d.a.lydall{at}ncl.ac.uk (E-mail)
Communicating editor: A. NICOLAS
| ABSTRACT |
|---|
Telomerase-defective budding yeast cells escape senescence by using homologous recombination to amplify telomeric or subtelomeric structures. Similarly, human cells that enter senescence can use homologous recombination for telomere maintenance, when telomerase cannot be activated. Although recombination proteins required to generate telomerase-independent survivors have been intensively studied, little is known about the nucleases that generate the substrates for recombination. Here we demonstrate that the Exo1 exonuclease is an initiator of the recombination process that allows cells to escape senescence and become immortal in the absence of telomerase. We show that EXO1 is important for generating type I survivors in yku70
mre11
cells and type II survivors in tlc1
cells. Moreover, in tlc1
cells, EXO1 seems to contribute to the senescence process itself.
BUDDING yeast cells, like almost all immortal eukaryotic cells, use telomerase to maintain the end of their chromosomes. Cells lacking telomerase components, for example, est1
, est2
, or tlc1
mutants, have been engineered and studied for their ability to escape replicative senescence (a state of cell cycle arrest caused by short and/or defective telomeres) and survive indefinite periods of time using a secondary mechanism of telomere maintenance. This mechanism appears to be based on break-induced replication (BIR), a variant of the main DSB-repair mechanism in budding yeast, homologous recombination, and is associated with amplification of telomeric or subtelomeric structures (![]()
![]()
![]()
Long-term survival without evidence of telomerase activity was found in
15% of malignant tumors, where it was termed alternative lengthening of telomeres (ALT; ![]()
![]()
![]()
![]()
![]()
It is clear that genes involved in recombination at double-strand breaks are also responsible for amplification of telomeres in the absence of telomerase (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
There are subtle differences between the recombination-amplification induced by telomere shortening and the recombination-repair induced by a double-strand break, despite the fact that they involve the same genes. For example, initiation of (sub) telomeric amplification is a relatively rare event, with approximately only one in a million cells able to complete this process; in contrast, double-strand breaks (DSBs) are highly efficiently repaired.
Although recombination proteins required to generate telomerase-independent survivors have been intensively studied, little was known about the nucleases that generate the substrate for recombination.
EXO1 encodes a 5' to 3' exonuclease with FLAP endonuclease activity (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
Here we present evidence that EXO1 is important for generating recombination-dependent, type I and II survivors, in two different types of senescent mutants: telomere capping defective (yku70
mre11
) and telomerase-negative (tlc1
) cells. We show that deletion of EXO1 delays the appearance of survivors for
3040 generations. Therefore, EXO1 appears to be one of the "initiators" of the recombination process that allow rare cells to escape senescence and became immortal in the absence of telomerase.
| MATERIALS AND METHODS |
|---|
Yeast strains:
All strains used in this study are isogenic, in the W303 background, and RAD5+. To construct strains, standard genetic procedures of transformation and tetrad analysis were followed (![]()
mre11
exo1
strains and their controls were made by crossing DLY1331 (mre11
::hisG::URA3) with DLY1408 (yku70
::HIS3 exo1
::LEU2). All tlcl
exo1
strains were made by crossing DLY1628 [tlc1
::HIS3 pTLC1:URA3 (pSD120 from D. Gottschling)] with DLY1948 (exo1
::LEU2 rad52
::TRP1). Diploid cells that had lost the pTLC1 plasmid were sporulated, dissected, and germinated.
Growth rate assay:
Cells of the appropriate genotype (four independent strains for each genotype of interest) were isolated from a fresh germination plate and grown in YPD medium overnight. The following morning, cells were counted using a hemocytometer, diluted to 1 x 105 cells/ml, and then incubated at 23°, with aeration. Every 23 hr, cell densities were measured and then the culture was diluted with fresh YPD liquid medium to a density of 105 cells/ml. During counting, cells were put on ice. This cycle was repeated for several days. At indicated time points, samples were collected for telomere length analysis.
Streak assay:
Cells of the appropriate genotype were picked from a fresh germination plate and streaked onto YPD plates. After incubation for 4 days at 23°, similar amounts of cells (
1 x 107 cells) from several independent colonies were picked and restreaked on YPD plates. This restreaking was repeated several times to allow senescence and appearance of survivors.
Microcolony assays:
Colony-purified yeast strains were inoculated into 1 ml YPD and grown overnight with aeration at 23° until they reached a concentration of
8 x 106 cells/ml. Cells were sonicated briefly and spread on plates. The plates were incubated at 23°. After an appropriate length of time, the colonies were photographed and the cell numbers in 100 colonies were counted/estimated.
Telomere and subtelomere Southern blots:
Southern blot analyses were performed to examine telomere and Y' lengths. Each time, cells from three or four independent mutants with the same genotype were pooled prior to DNA extraction, except for Southern blot analysis of single colonies. Yeast genomic DNA was isolated and
20 ng of DNA was digested with XhoI and separated on a 0.8% agarose gel. DNA was then transferred to a Magna Nylon membrane (Genetic Research Instrumentation) and UV crosslinked. The membrane was then hybridized with a Y'-TG probe (pHT128; ![]()
| RESULTS |
|---|
EXO1 is important for generating survivors in yku70
mre11
senescent cells:
Initiation of (sub)telomeric amplification in the absence of telomerase is a rare event. Factors involved in the initiation of survivors were still unknown, but we speculated that EXO1 might be one, because of its role in degradation of unprotected telomeres (![]()
mutants were targeted by the Exo1p exonuclease. EXO1 was important for resecting the 5' AC strand, from telomeres toward centromeres, leaving behind a detectable 3' overhang, up to 1 kb long in yku70
strains (![]()
![]()
We, therefore, tested the role of EXO1 in senescence and survival of cells with telomere defects caused by the absence of telomere protective genes YKU70 and MRE11. This model of senescence and survival is based on the observation that yku70
mre11
double mutants senesce very rapidly, during the early growth of germinated spores (![]()
![]()
![]()
We monitored growth of yku70
mre11
double mutants and yku70
mre11
exo1
triple mutants. Cells were taken directly from the germination plate (four independent strains of each genotype) and incubated in liquid at 23° for several days. At 23°, wild-type strains would divide
10 times a day. Cell densities were scored every 23 hr, followed by dilution to 105 cells/ml and continued incubation. At 23°, yku70
and yku70
exo1
cells reached and maintained densities of
0.5 x 108 cells/ml, similar to the wild type, while other control mutants, mre11
and mre11
exo1
, reached densities 5-fold lower than those of the wild type (Fig 1A). In contrast, yku70
mre11
and yku70
mre11
exo1
cells were in crisis during the early days of the experiment, when they had densities 200-fold lower than those of the wild type, consistent with early entry into senescence (Fig 1A).
|
Both types of senescent mutants, yku70
mre11
(EXO1+) and yku70
mre11
exo1
, were able to generate survivors, but with different dynamics. While EXO1+ survivors escaped senescence early (days 45) and grew, after 2 days, at growth rates (determined by cell density after 23 hr growth) similar to those of mre11
mutants, exo1
survivors appeared more slowly and gradually reached, after 15 days in liquid culture, a 5-fold lower cell density, compared with mre11
cells (Fig 1A).
The data above suggest that EXO1 plays a significant, but not essential, role in generating survivors. Another possibility would be that EXO1 is important for cell vitality in an mre11
background, even in the absence of senescence. When growth rates of mre11
exo1
cells are compared with those of mre11
mutants, it appears that exo1
deletion did indeed cause a kind of crisis during the first 4 days, when mre11
exo1
mutants daily reached only
25% of the cell density of mre11
strains (Fig 1A; ![]()
exo1
strains improved during the following generations, oscillating between 55 and 98% of the mre11
growth. Thus, the requirement for EXO1 was stronger in yku70
mre11
survivors than in mre11
mutants. Interestingly, deletion of EXO1 in yku70
cells shows an effect opposite to that in mre11
cells, because exo1
mutation improves the growth rate of yku70
mutants
15% at 23° (Fig 1A). At 37°, an exo1
even rescues the inviability of yku70
mutants (![]()
The requirement for EXO1 in recovery from senescence was also tested by growth on plates, when comparable amounts of cells from germination plates were spread on fresh YPD plates (passage 1) and incubated at 23° for 4 days (Fig 1B). Several passages were performed consecutively. This experiment confirmed that early generations of yku70
mre11
(EXO1+) and yku70
mre11
exo1
mutants were in a state of minimal growth, presumably senescent (passage 1), and that EXO1+ strains generated survivors more rapidly (passage 2) compared with exo1
strains (passage 3). Also, EXO1+ survivors grew notably better than exo1
survivors (passage 3), and a difference in growth was maintained even after 15 passages, which is equivalent to 600 wild-type generations (Fig 1D, compare size of individual colonies; data not shown).
EXO1 is required for maintenance of survivors:
The continued growth defect in yku70
mre11
exo1
could have many possible explanations, such as slow metabolic rate, longer cell cycle, decreased viability, high rate of resenescence, and/or delay in reappearance of survivors. It is known that in telomerase-defective (est1
) survivors, the senescence phenotype reappears in some subclones (![]()
|
Although a number of nondividing cells (single-cell "colonies") or cells with a large bud (two-cell colonies) were microscopically detected after 24 hr in all mutants with a mre11
background, the percentage of these one- or two-cell colonies in yku70
mre11
survivors was similar to that in mre11
or mre11
exo1
control strains and did not exceed 15% under normal conditions (Fig 2; data not shown). By contrast, yku70
mre11
exo1
survivors had a high fraction of one- or two-cell colonies (
35%) after 24 hr, suggesting they were confronted with high levels of resenescence and/or difficulties in regeneration of survivors, which can explain the lower cell density reached by these mutants in liquid culture. Also, it is clear that some yku70
mre11
exo1
colonies were similar in size to yku70
mre11
EXO1+ colonies, and therefore a difference in growth caused by a slow metabolic rate or delayed cell cycle can be excluded (Fig 2).
EXO1 increases the rate of Y' amplification in yku70
mre11
survivors (type I survivors):
Some cells can escape senescence and generate survivors. In yeast, presumably also in mammalian cells, this occurs by correction of the telomeric defect. Repair proteins that belong to the recombination pathways are able to amplify subtelomeric regions (in yeast, Y' regions), generating type I survivors, or amplify terminal telomeric TG repeats, generating type II survivors. It is known that Rad50p, which acts in a complex with Mre11p, is required to maintain type II survivors, because in a rad50
background, type I survivors replace type II survivors very early (![]()
background as well.
Also, the fact that exo1
survivors appear late and maintain a growth defect, compared with the EXO1+ strains, raised the possibility that exo1
survivors were using a different survival mechanism. To address the mechanism, we performed Southern blots to detect Y' or TG amplifications (Fig 3). Cells were collected every 3 days and DNA was cut with XhoI and probed with a Y'-TG probe; that gave three fragments,
6.5, 5.5, and 1.3 kb in wild-type cells. The two larger fragments correspond to repetitive Y''s, while the shortest fragment is the terminal 1 kb of Y' and also contains
350 bp of telomeric TG repeats (Fig 3A).
|
In mre11
control strains, the telomeric fragment was shorter than that in wild type (Fig 3B), consistent with previous data (![]()
![]()
strains, maintained by telomerase, apparently does not influence the length or intensity of (sub)-telomeric fragments, consistent with earlier observations (Fig 3B; ![]()
![]()
exo1
strains improved after several days in liquid culture (Fig 1A), but this growth improvement did not correlate with any notable change at the telomeres of these strains (Fig 3B).
However, in senescent yku70
mre11
cells, the effect of exo1
was obvious. During the first 3 days in culture, yku70
mre11
cells were senescent and the larger fragments corresponding to Y' looked similar to wild type, while the short fragment appeared less intense, presumably due to loss of telomeric sequences in many of these cells (Fig 3B). But after 6 days, yku70
mre11
cells had already amplified the Y' repeats (type I survivors), and this amplification apparently remained constant afterward (days 612; Fig 3B). Deletion of EXO1 from yku70
mre11
cells considerably slowed the rate of Y' amplification. Amplification occurred slowly, but progressively during 312 days in culture; however, even after 12 days, the Y' amplification was less pronounced in yku70
mre11
exo1
cells than in yku70
mre11
cells after 6 days in culture (Fig 3B). Therefore, cells lacking EXO1 had difficulty in generating type I survivors. The difference in dynamics of Y' amplification, in exo1
vs. EXO1+ survivors, is not a consequence of poor cell growth, because similar amounts of DNA were analyzed in Southern blot assays (see DNA loading control, Fig 3B) and, initially, Y' amplifications occur during senescence. Rather, the growth defect might be explained by difficulties and delays in amplification of Y' regions in yku70
mre11
exo1
strains due to the absence of EXO1.
YKU70 inhibits the maintenance of type I survivors:
We have shown that Exo1 degrades telomeres in yku70
mutants (![]()
mre11
strains. These strains senesce due to the absence of the telomerase RNA template, Tlc1, while deletion of Mre11 ensures that only type I survivors can be generated. We monitored senescence and survival in experiments similar to those described in Fig 1. In this experiment, an exo1
decreased the density of tlc1
mre11
cells before and after senescence (Fig 4A). This is partially due to the synergic effect of exo1
and mre11
deletions in decreasing the cell viability, as previously mentioned. A second phenomenon was noted: during the early postsenescence period, tlc1
mre11
survivors grew poorly compared with yku70
mre11
survivors and did not reach the growth levels of mre11
single mutants, as yku70
mre11
survivors did (Fig 4A vs. Fig 1A). Also, the Y' amplification in tlc1
mre11
survivors was inferior to the Y' amplification in yku70
mre11
survivors (Fig 4B vs. Fig 3B). The data suggest that the presence of Yku70 makes the maintenance of type I survivors difficult and might explain why tlc1
cells preferentially maintain type II survivors.
|
EXO1 opposes adaptation and plays a role in generating type I survivors in tlc1
mre11
cells:
We next addressed the question of whether EXO1 plays a role in generating type I survivors, in the presence of YKU70, in tlc1
mre11
mutants. Fig 4A shows that tlc1
mre11
exo1
survivors grew about fivefold less than tlc1
mre11
survivors, during the early days of the postsenescence period (days 912). This may be due to the synthetic effect of mre11
and exo1
in decreasing the cell viability. However, was the escape from senescence and early postsenescence growth of tlc1
mre11
exo1
strains due to recombination events that generated type I survivors? To test this, we deleted RAD52, which is essential for recombination. It is clear from Fig 4A that RAD52-recombination defective, tlc1
mre11
exo1
rad52
strains also escape senescence and their postsenescent growth curve almost overlaps with the growth curve of tlc1
mre11
exo1
mutants, during the first 17 days in culture. By contrast, tlc1
mre11
rad52
cells did not escape senescence. Thus, tlc1
mre11
exo1
rad52
cells appeared to be adapting to the telomere defect, rather than using recombination to overcome senescence.
Thus, early postsenescence growth of tlc1
mre11
exo1 cells was RAD52 independent, while growth of tlc1
mre11
cells during the same period was strictly RAD52 dependent. Later on, RAD52+ strains amplified the Y' repeats, tlc1
mre11
exo1
mutants to a lesser extent than tlc1
mre11
mutants (Fig 4B), while rad52
survivors showed no amplification of subtelomeric regions (data not shown). Adaptation is defined as escape from the cell cycle arrest without repair of the DNA damage (![]()
![]()
Our interpretation is that EXO1 is, indeed, required to generate type I survivors in tlc1
mre11
mutants, but also to suppress the adaptation to telomeric damage and the recombination-independent escape from senescence.
EXO1 plays a role in generating type II survivors in tlc1
cells:
If EXO1 plays a role in the amplification of subtelomeric repeats, presumably by generating long 3' overhangs that would invade hom(e)ologous structures, what about its role in type II survivors? Type II survivors amplify the TG-telomeric repeats, with help from a nuclease/helicase complex (Rad50p/Mre11p/Xrs2p), a helicase (Srs2p or Sgs1p), and recombination proteins (Rad52p and Rad59p; ![]()
In experiments similar to those described in Fig 1, we monitored the senescence and survival of tlc1
exo1
cells vs. tlc1
cells (Fig 5). The strains were germinated from spores that had inherited the normal telomere length from their parents. During the presenescent period, tlc1
exo1
strains grew
1.5-fold better than tlc1
EXO1+ single mutants each day (Fig 5A; note the lack of overlap of error bars on days 3 and 4). This suggests that in the absence of telomerase, EXO1 contributes to telomere shortening and senescence. However, this phenomenon was not observed in strains that lack MRE11 (Fig 4A). It is possible that the synthetic effect of mre11
and exo1
mutations in decreasing cell viability (presumably for reasons other than telomere damage, because mre11
exo1
and mre11
cells have similarly short telomeres; Fig 3B) counteracts the effect of exo1
in presenescent mre11
cells.
|
As telomeres progressively shortened, cells became senescent. The vast majority of cells stopped cell division after 6 days in liquid culture, when tlc1
and tlc1
exo1
cells had 20- to 25-fold lower densities, compared with their growth rate from day 1 (Fig 5A). Soon after, tlc1
cells generated survivors that reached their full growth potential within 2 days (day 8). By contrast, tlc1
exo1
cells grew poorly and needed more time (1112 days total) to achieve a better growth rate, still 1.6-fold less than that of tlc1
or exo1
cells (Fig 5A). This indicates that EXO1 plays a role in generating survivors in a tlc1
background.
Since telomerase-defective tlc1
cells entered senescence more slowly than yku70
mre11
cells (compare Fig 1A and Fig 5A) we were able to monitor the effect of EXO1 on telomere degradation as cells entered senescence. We purified DNA from cells as early as possible after they had germinated and every day thereafter. The effect of EXO1 on telomere shortening in presenescent cells was clear. In EXO1+ tlc1
cells significant telomere shortening had occurred by the time we were first able to purify DNA (as the spores germinated and grew from a single cell to a colony of
108 cells). After this, during days 17, telomere shortening appeared to stop. In contrast, tlc1
exo1
cells contained significantly longer telomeres at day 0 that slowly declined over the next 6 days, to reach a length similar to that in tlc1
cells by day 7 (Fig 5B).
To understand the role of Exo1p during recovery from senescence, Southern blots were used to analyze the dynamics of telomere amplification in tlc1
exo1
double mutants vs. tlc1
single mutants (Fig 5C). After 6 days in culture, both types of mutants had short telomeres. After 8 days in culture, tlc1
cells had amplified the telomeric TG sequences, generating type II survivors, while the short telomeres from tlc1
exo1
cells looked unchanged (Fig 5C). After 10 days, tlc1
exo1
cells showed little evidence of telomere amplification, and also their Y' repeats were indistinguishable from wild-type Y' repeats (Fig 5C). The tlc1
exo1
cells significantly amplified their telomeres after 12 days in culture. The pattern of telomere amplification in tlc1
exo1
survivors was also different from that in tlc1
mutants: they seemed to maintain a fraction of short telomeres, together with amplified telomeric TG sequences (Fig 5C).
Cells containing short Y' telomeres and extensive TG repeats are not commonly observed. We wondered if this pattern represented the initial phase in the generation of type II survivors. To test this we cloned 12 colonies from cells that had been passaged on agar plates for 8 days. At this point very few cells formed colonies. Four of 6 tlc1
colonies were survivors: 2 (C and E) were type I, and 2 (A and F) were type II (Fig 5D). Both of these early type II survivors still contained a lower terminal Y' fragment, similar to the tlc1
exo1
strains at day 12 (Fig 5C). When we examined DNA from the tlc1
exo1
cells, only 1 colony (G) had generated a type I survivor at this point, while the other colonies showed little (I and L have a weak 1.3-kb band) or no evidence for amplification and were, possibly, late senescent colonies (i.e., colonies derived from presenescent cells that have previously spent a long time in G1, before Start, due to the caloric restriction caused by a large number of cells competing for nutrients on a limited agar surface).
| DISCUSSION |
|---|
With respect to its activity at defective telomeres, EXO1 encodes an exonuclease able to attack, degrade, and alert checkpoint pathways in yku70
and cdc13-1 mutants (![]()
We show that EXO1 plays three roles in cells that enter senescence. First, the presence of EXO1 in mre11
yku70
or tlc1
cells appears to contribute to entry into senescence. Second, the presence of EXO1 in the same cells contributes to rapid escape from senescence by generating type I and type II survivors. Thus, EXO1 accelerates entry into and exit from senescence. Third, EXO1 inhibits adaptation to senescence. All these effects of Exo1 can be explained by its 5' to 3' nuclease activity that generates single-stranded DNA overhangs at telomeres.
In yku70
mre11
cells, Exo1p is able to generate long 3' overhangs in subtelomeric regions (![]()
cells, presumably due to redundant nuclease activities.
|
In tlc1
cells, EXO1 is also important for generating type II survivors. Type II survivors might represent the product of a "disrupted" recombination pathway that had difficulty in progressing into the Y' regions, due to the protective presence/activity of both Yku70p/Yku80p and MRE11/RAD50/XRS2 complexes, and that specializes in amplification of TG repeats. Exo1p activity is presumably required to degrade the telomeric 5' strand produced by a helicase. It is known that Sgs1 and Srs2 are required for BIR and/or generation of type II survivors (![]()
![]()
![]()
![]()
In previous studies, an antirecombination activity has been attributed to the mismatch repair proteins in Escherichia coli (![]()
![]()
strains (![]()
![]()
![]()
![]()
![]()
deletion on telomere recombination would be indirect, by increasing the amount of (unbound) Exo1p.
In conclusion, EXO1 is important for generating type I survivors in yku70
mre11
cells and type II survivors in tlc1
cells. Moreover, EXO1 seems to contribute to the senescence process itself, in tlc1
cells. We speculate that in human cells also, interference with EXO1 or other nucleases active at uncapped telomeres might slow down both the entry into senescence and the speed of generating recombination-dependent survivors.
| FOOTNOTES |
|---|
1 Present address: School of Clinical Medical Sciences-Gerontology, University of Newcastle, Henry Wellcome Laboratory for Biogerontology Research, Newcastle General Hospital, Newcastle upon Tyne, NE4 6BE, United Kingdom. ![]()
| ACKNOWLEDGMENTS |
|---|
We thank A. Bertuch and V. Lundblad for sharing unpublished data, R. Blankley for a tlc1
deletion strain, D. Gottschling for the TLC1 plasmids, and H. Tsubouchi and H. Ogawa for the Y'-TG plasmid. The Wellcome Trust funded this work.
Manuscript received June 26, 2003; Accepted for publication November 24, 2003.
| LITERATURE CITED |
|---|
ADAMS, A., D. E. GOTTSCHLING, C. A. KAISER and T. STEARNS, 1997 Methods in Yeast Genetics. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
BOULTON, S. J. and S. P. JACKSON, 1998 Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J. 17:1819-1828.[CrossRef][Medline]
CHAMANKHAH, M., T. FONTANIE, and W. XIAO, 2000 The Saccharomyces cerevisiae mre11(ts) allele confers a separation of DNA repair and telomere maintenance functions. Genetics 155:569-576.
CHEN, Q., A. IJPMA, and C. W. GREIDER, 2001 Two survivor pathways that allow growth in the absence of telomerase are generated by distinct telomere recombination events. Mol. Cell. Biol. 21:1819-1827.
COHEN, H. and D. A. SINCLAIR, 2001 Recombination-mediated lengthening of terminal telomeric repeats requires the Sgs1 DNA helicase. Proc. Natl. Acad. Sci. USA 98:3174-3179.
DATTA, A., A. ADJIRI, L. NEW, G. F. CROUSE, and S. JINKS ROBERTSON, 1996 Mitotic crossovers between diverged sequences are regulated by mismatch repair proteins in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:1085-1093.[Abstract]
DUBOIS, M. L., Z. W. HAIMBERGER, M. W. MCINTOSH, and D. E. GOTTSCHLING, 2002 A quantitative assay for telomere protection in Saccharomyces cerevisiae. Genetics 161:995-1013.
FIORENTINI, P., K. N. HUANG, D. X. TISHKOFF, R. D. KOLODNER, and L. S. SYMINGTON, 1997 Exonuclease I of Saccharomyces cerevisiae functions in mitotic recombination in vivo and in vitro. Mol. Cell. Biol. 17:2764-2773.[Abstract]
GROBELNY, J. V., M. KULP-MCELIECE, and D. BROCCOLI, 2001 Effects of reconstitution of telomerase activity on telomere maintenance by the alternative lengthening of telomeres (ALT) pathway. Hum. Mol. Genet. 10:1953-1961.
HAKIN-SMITH, V., D. A. JELLINEK, D. LEVY, T. CARROLL, and M. TEO et al., 2003 Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme. Lancet 361:836-838.[CrossRef][Medline]
HENSON, J. D., A. A. NEUMANN, T. R. YEAGER, and R. R. REDDEL, 2002 Alternative lengthening of telomeres in mammalian cells. Oncogene 21:598-610.[CrossRef][Medline]
HUANG, P., F. E. PRYDE, D. LESTER, R. L. MADDISON, and R. H. BORTS et al., 2001 SGS1 is required for telomere elongation in the absence of telomerase. Curr. Biol. 11:125-129.[CrossRef][Medline]
JOHNSON, F. B., R. A. MARCINIAK, M. MCVEY, S. A. STEWART, and W. C. HAHN et al., 2001 The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 20:905-913.[CrossRef][Medline]
KHAZANEHDARI, K. A. and R. H. BORTS, 2000 EXO1 and MSH4 differentially affect crossing-over and segregation. Chromosoma 109:94-102.[CrossRef][Medline]
KIRKPATRICK, D. T., J. R. FERGUSON, T. D. PETES, and L. S. SYMINGTON, 2000 Decreased meiotic intergenic recombination and increased meiosis I nondisjunction in exo1 mutants of Saccharomyces cerevisiae. Genetics 156:1549-1557.
LE, S., J. K. MOORE, J. E. HABER, and C. W. GREIDER, 1999 RAD50 and RAD51 define two pathways that collaborate to maintain telomeres in the absence of telomerase. Genetics 152:143-152.
LEE, S. E., J. K. MOORE, A. HOLMES, K. UMEZU, and R. D. KOLODNER et al., 1998 Saccharomyces Ku70, Mre11/Rad50, and RPA proteins regulate adaptation to G2/M arrest after DNA damage. Cell 94:399-409.[CrossRef][Medline]
LUNDBLAD, V., 2002 Telomere maintenance without telomerase. Oncogene 21:522-531.[CrossRef][Medline]
LUNDBLAD, V. and E. H. BLACKBURN, 1993 An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 73:347-360.[CrossRef][Medline]
LYDALL, D., 2003 Hiding at the ends of yeast chromosomes: telomeres, nucleases and checkpoint pathways. J. Cell Sci. 116:4057-4065.
MARINGELE, L. and D. LYDALL, 2002 EXO1-dependent single-stranded DNA at telomeres activates subsets of DNA damage and spindle checkpoint pathways in budding yeast yku70
mutants. Genes Dev. 16:1919-1933.
MCEACHERN, M. J. and E. H. BLACKBURN, 1995 Runaway telomere elongation caused by telomerase RNA gene mutations. Nature 376:403-409.[CrossRef][Medline]
MOREAU, S., E. A. MORGAN, and L. S. SYMINGTON, 2001 Overlapping functions of the Saccharomyces cerevisiae Mre11, Exo1 and Rad27 nucleases in DNA metabolism. Genetics 159:1423-1433.
PETIT, M. A., J. DIMPFL, M. RADMAN, and H. ECHOLS, 1991 Control of large chromosomal duplications in Escherichia coli by the mismatch repair system. Genetics 129:327-332.[Abstract]
PRYDE, F. E. and E. J. LOUIS, 1997 Saccharomyces cerevisiae telomeres. A review. Biochemistry 62:1232-1241.[Medline]
REDDEL, R. R., T. M. BRYAN, and J. P. MURNANE, 1997 Immortalized cells with no detectable telomerase activity. A review. Biochemistry 62:1254-1262.[Medline]
RITCHIE, K. B. and T. D. PETES, 2000 The Mre11p/Rad50p/Xrs2p complex and the Tel1p function in a single pathway for telomere maintenance in yeast. Genetics 155:475-479.
RIZKI, A. and V. LUNDBLAD, 2001 Defects in mismatch repair promote telomerase-independent proliferation. Nature 411:713-716.[CrossRef][Medline]
SIGNON, L., A. MALKOVA, M. L. NAYLOR, H. KLEIN, and J. E. HABER, 2001 Genetic requirements for RAD51- and RAD54-independent break-induced replication repair of a chromosomal double-strand break. Mol. Cell. Biol. 21:2048-2056.
SOKOLSKY, T. and E. ALANI, 2000 EXO1 and MSH6 are high-copy suppressors of conditional mutations in the MSH2 mismatch repair gene of Saccharomyces cerevisiae. Genetics 155:589-599.
SUGAWARA, N., G. IRA, and J. E. HABER, 2000 DNA length dependence of the single-strand annealing pathway and the role of Saccharomyces cerevisiae RAD59 in double-strand break repair. Mol. Cell. Biol. 20:5300-5309.
SYMINGTON, L. S., L. E. KANG, and S. MOREAU, 2000 Alteration of gene conversion tract length and associated crossing over during plasmid gap repair in nuclease-deficient strains of Saccharomyces cerevisiae. Nucleic Acids Res. 28:4649-4656.
TENG, S. C. and V. A. ZAKIAN, 1999 Telomere-telomere recombination is an efficient bypass pathway for telomere maintenance in Saccharomyces cerevisiae. Mol. Cell. Biol. 19:8083-8093.
TISHKOFF, D. X., A. L. BOERGER, P. BERTRAND, N. FILOSI, and G. M. GAIDA et al., 1997 Identification and characterization of Saccharomyces cerevisiae EXO1, a gene encoding an exonuclease that interacts with MSH2. Proc. Natl. Acad. Sci. USA 94:7487-7492.
TOCZYSKI, D. P., D. J. GALGOCZY, and L. H. HARTWELL, 1997 CDC5 and CKII control adaptation to the yeast DNA damage checkpoint. Cell 90:1097-1106.[CrossRef][Medline]
TRAN, P. T., J. A. SIMON, and R. M. LISKAY, 2001 Interactions of Exo1p with components of MutLalpha in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 98:9760-9765.
TRAN, P. T., N. ERDENEZ, S. DUDLEY, and R. M. LISKAY, 2002 Characterization of nuclease-dependent functions of Exo1p in Saccharomyces cerevisiae. DNA Repair 1:895-912.[CrossRef][Medline]
TSUBOUCHI, H. and H. OGAWA, 2000 Exo1 roles for repair of DNA double-strand breaks and meiotic crossing over in Saccharomyces cerevisiae. Mol. Biol. Cell 11:2221-2233.
ULANER, G. A., H. Y. HUANG, J. OTERO, Z. ZHAO, and L. BEN-PORAT et al., 2003 Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma. Cancer Res. 63:1759-1763.
This article has been cited by other articles:
![]() |
L. H. Bechard, B. D. Butuner, G. J. Peterson, W. McRae, Z. Topcu, and M. J. McEachern Mutant Telomeric Repeats in Yeast Can Disrupt the Negative Regulation of Recombination-Mediated Telomere Maintenance and Create an Alternative Lengthening of Telomeres-Like Phenotype Mol. Cell. Biol., February 1, 2009; 29(3): 626 - 639. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Nimonkar, A. Z. Ozsoy, J. Genschel, P. Modrich, and S. C. Kowalczykowski Human exonuclease 1 and BLM helicase interact to resect DNA and initiate DNA repair PNAS, November 4, 2008; 105(44): 16906 - 16911. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Y. Lee, J. L. Mogen, A. Chavez, and F. B. Johnson Sgs1 RecQ Helicase Inhibits Survival of Saccharomyces cerevisiae Cells Lacking Telomerase and Homologous Recombination J. Biol. Chem., October 31, 2008; 283(44): 29847 - 29858. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Longhese DNA damage response at functional and dysfunctional telomeres Genes & Dev., January 15, 2008; 22(2): 125 - 140. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. L. Pike and J. Heierhorst Mdt1 Facilitates Efficient Repair of Blocked DNA Double-Strand Breaks and Recombinational Maintenance of Telomeres Mol. Cell. Biol., September 15, 2007; 27(18): 6532 - 6545. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Grandin and M. Charbonneau Control of the yeast telomeric senescence survival pathways of recombination by the Mec1 and Mec3 DNA damage sensors and RPA Nucleic Acids Res., February 16, 2007; 35(3): 822 - 838. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Corda, S. E. Lee, S. Guillot, A. Walther, J. Sollier, A. Arbel-Eden, J. E. Haber, and V. Geli Inactivation of Ku-Mediated End Joining Suppresses mec1{Delta} Lethality by Depleting the Ribonucleotide Reductase Inhibitor Sml1 through a Pathway Controlled by Tel1 Kinase and the Mre11 Complex Mol. Cell. Biol., December 1, 2005; 25(23): 10652 - 10664. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Doherty, S. Sharma, L. A. Uzdilla, T. M. Wilson, S. Cui, A. Vindigni, and R. M. Brosh Jr. RECQ1 Helicase Interacts with Human Mismatch Repair Factors That Regulate Genetic Recombination J. Biol. Chem., July 29, 2005; 280(30): 28085 - 28094. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, N. Erdmann, R. J. Giannone, J. Wu, M. Gomez, and Y. Liu An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres PNAS, July 19, 2005; 102(29): 10256 - 10260. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Maringele and D. Lydall Telomerase- and recombination-independent immortalization of budding yeast Genes & Dev., November 1, 2004; 18(21): 2663 - 2675. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Liberti and L. J. Rasmussen Is hEXO1 a Cancer Predisposing Gene? Mol. Cancer Res., August 1, 2004; 2(8): 427 - 432. [Full Text] [PDF] |
||||
- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Email this article to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Maringele, L.
- Articles by Lydall, D.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Maringele, L.
- Articles by Lydall, D.











